Weakness after complete remission of acute myeloid leukemia requires continued post-remission therapy, including consolidation, intensification, maintenance, extramedullary leukemia control, and hematopoietic stem cell transplantation. Weakness is a symptom that can occur in acute myeloid leukemia, and weakness after complete remission is still related to the stage of treatment. The treatment of acute myeloid leukemia should be carried out in stages: 1. The first stage is induction therapy: the aim is to kill leukemia cells and achieve normalization of routine bone marrow examination (bone marrow smear classification or biopsy) (complete remission). 2. The second stage is post-remission treatment (including consolidation, intensification, maintenance therapy and extramedullary leukemia control as well as hematopoietic stem cell transplantation, etc.): the aim is to remove residual leukemia cells that cannot be detected by conventional examination methods, in order to minimize relapse and strive for long-term survival. Specific medications include cytarabine, zorubicin, fludarabine, leucovorin, methotrexate, and others. If acute myeloid leukemia is diagnosed, it is recommended that standardized treatment under the guidance of a physician be carried out as early as possible in order to reduce the adverse effects of the disease. Maintenance therapy should continue to be given in stages after the acute myeloid leukemia is in complete remission.